ADVFN US – Market Content Editor
-

Compugen shares jump nearly 5% after strong Q4 earnings beat
Compugen Ltd. (NASDAQ:CGEN) shares climbed almost 5% in premarket trading on Monday after the company reported fourth-quarter results that far exceeded analyst expectations, supported by a strategic royalty monetization deal with AstraZeneca. The clinical-stage cancer immunotherapy developer posted adjusted earnings per share of $0.60 for the quarter, sharply outperforming the analyst consensus forecast of a…
-

Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares gained nearly 3% in premarket trading on Monday after the company reported fourth-quarter results that topped analyst expectations and issued 2026 revenue guidance above consensus forecasts. The biopharmaceutical company posted adjusted earnings per share of $0.06 for the fourth quarter, exceeding analyst estimates of $0.02 by $0.04. Quarterly revenue…
-

Sealed Air tops Q4 forecasts on stronger revenue and earnings performance
Sealed Air Corporation (NYSE:SEE) reported fourth-quarter results on Monday that came in ahead of analyst expectations, with both revenue and earnings exceeding consensus forecasts. The company posted adjusted earnings per share of $0.77, surpassing the analyst estimate of $0.73. Shares were little changed following the announcement, edging up 0.05% in premarket trading. Quarterly revenue totaled…
-

Astrana Health shares rise more than 3% after earnings beat and upbeat outlook
Astrana Health, Inc. (NASDAQ:ASTH) shares gained over 3% in premarket trading on Monday after the healthcare management company reported fourth-quarter results that surpassed analyst expectations and pointed to continued growth momentum heading into 2026. The company posted adjusted earnings per share of $0.54 for the fourth quarter, significantly exceeding the analyst consensus forecast of $0.10…
-

uniQure shares plunge 45% after FDA setback on Huntington’s gene therapy
Shares of uniQure N.V. (NASDAQ:QURE) dropped 45% on Monday after the company revealed that the U.S. Food and Drug Administration declined to support its proposed regulatory pathway for the approval of AMT-130, an experimental gene therapy targeting Huntington’s disease. According to final minutes from a Type A meeting held on January 30, the FDA said…
-

Yatsen shares slide 12% after fourth-quarter earnings miss expectations
Yatsen Holding Limited (NYSE:YSG) shares fell nearly 12% in premarket trading on Monday after the China-based beauty company reported fourth-quarter results that came in below earnings expectations. The company posted adjusted earnings per ADS of $0.07 for the quarter, missing analyst forecasts despite delivering improved profitability compared with the prior year. Fourth-quarter revenue rose 20.1%…
-

Venture Global shares jump 7% after fourth-quarter earnings surpass expectations
Venture Global, Inc. (NYSE:VG) shares surged 7% in premarket trading on Monday after the liquefied natural gas exporter reported fourth-quarter results that exceeded profit forecasts, supported by a sharp increase in production volumes. The company posted adjusted earnings per share of $0.41 for the fourth quarter, ahead of analyst estimates of $0.35. Quarterly revenue totaled…
-

Norwegian Cruise Line slides after soft 2026 outlook despite Q4 earnings beat
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) shares fell 7.8% in premarket trading after the company delivered stronger-than-expected fourth-quarter earnings but disappointed investors with weaker revenue and fiscal 2026 guidance that came in below market forecasts. The cruise operator reported adjusted earnings per share of $0.28 for the fourth quarter, ahead of analyst expectations of $0.26.…
-

RadNet shares gain 3% following $270 million acquisition of AI firm Gleamer
RadNet Inc (NASDAQ:RDNT) shares rose 3% to $71.91 in premarket trading on Monday after the U.S.-based imaging services provider announced plans to acquire French radiology artificial intelligence company Gleamer in an all-cash deal valued at up to €230 million ($270 million). The transaction will position RadNet’s DeepHealth division as the largest global supplier of clinical…
-

Energy stocks advance as oil prices surge amid Middle East tensions
Shares of U.S. energy companies moved higher in premarket trading on Monday, tracking a sharp rise in crude oil prices following an escalation of conflict in the Middle East. Brent crude futures jumped as much as 13% to $82.37 per barrel — their highest level since January 2025 — before easing back to $79.39 per…